- Home
- KMDA vs BALY Comparison
KMDA vs BALY Comparison
Compare KMDA & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- BALY
- Stock Information
- Founded
- KMDA 1990
- BALY 2004
- Country
- KMDA Israel
- BALY United States
- Employees
- KMDA N/A
- BALY 10000
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- BALY Hotels/Resorts
- Sector
- KMDA Health Care
- BALY Consumer Discretionary
- Exchange
- KMDA Nasdaq
- BALY Nasdaq
- Market Cap
- KMDA 410.6M
- BALY 482.4M
- IPO Year
- KMDA N/A
- BALY N/A
- Fundamental
- Price
- KMDA $6.95
- BALY $10.57
- Analyst Decision
- KMDA Strong Buy
- BALY Hold
- Analyst Count
- KMDA 2
- BALY 7
- Target Price
- KMDA $13.00
- BALY $18.00
- AVG Volume (30 Days)
- KMDA 50.0K
- BALY 363.4K
- Earning Date
- KMDA 11-12-2025
- BALY 02-19-2025
- Dividend Yield
- KMDA 2.90%
- BALY N/A
- EPS Growth
- KMDA 27.97
- BALY N/A
- EPS
- KMDA 0.32
- BALY N/A
- Revenue
- KMDA $169,517,000.00
- BALY $2,481,783,000.00
- Revenue This Year
- KMDA $14.49
- BALY $3.06
- Revenue Next Year
- KMDA $10.12
- BALY N/A
- P/E Ratio
- KMDA $20.92
- BALY N/A
- Revenue Growth
- KMDA 9.67
- BALY 2.80
- 52 Week Low
- KMDA $5.17
- BALY $9.74
- 52 Week High
- KMDA $9.16
- BALY $18.38
- Technical
- Relative Strength Index (RSI)
- KMDA 44.35
- BALY 63.00
- Support Level
- KMDA $6.84
- BALY $9.75
- Resistance Level
- KMDA $7.15
- BALY $11.10
- Average True Range (ATR)
- KMDA 0.19
- BALY 0.64
- MACD
- KMDA -0.00
- BALY 0.08
- Stochastic Oscillator
- KMDA 23.02
- BALY 78.35
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.